bpc 157 neuroprotection BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers High-level overview of pathways modulated
Description
Aljabari B, Calogero AE, Perdichizzi A, et al
Mild pain and swelling typically resolve within 48-72 hours
Reconstitution, Storage and Handling BPC-157 is supplied as a lyophilised powder and requires reconstitution before use in research protocols
A model based upon this is described and the results so obtained compare well with exptl
